Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Accrued Liabilities
Meridian Bioscience Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Accrued Liabilities
$25.7m
|
CAGR 3-Years
30%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Accrued Liabilities
$144.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Accrued Liabilities
$590m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Accrued Liabilities
$496.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Accrued Liabilities
$146.2m
|
CAGR 3-Years
61%
|
CAGR 5-Years
43%
|
CAGR 10-Years
17%
|
See Also
What is Meridian Bioscience Inc's Accrued Liabilities?
Accrued Liabilities
25.7m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Accrued Liabilities amounts to 25.7m USD.
What is Meridian Bioscience Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
29%
Over the last year, the Accrued Liabilities growth was -17%. The average annual Accrued Liabilities growth rates for Meridian Bioscience Inc have been 30% over the past three years , 29% over the past five years .